NF2-mutant glioblastomas have several theorized pathways, excluding Hippo signaling, while studies on NF2-mutant prostate cancer simply detail other tumor suppressors that are commonly associated with NF2 in those tumors. This evidence concerns the gene NF2 and prostate cancer.